![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » JAPAN APPROVES SCHERING-PLOUGH'S TEMODAL
JAPAN APPROVES SCHERING-PLOUGH'S TEMODAL
Schering-Plough Corporation has announced that the Japan Ministry of Health, Labor and Welfare (MHLW) has approved TEMODAL (temozolomide) Capsules for the treatment of malignant glioma. The approval of TEMODAL by the MHLW follows a priority review of the New Drug Application (J-NDA) submission, which was granted in September of 2005 in order to satisfy an unmet medical need in Japanese patients. TEMODAL, marketed as TEMODAR in the US, is approved in 77 countries.
BioSpectrum (http://www.biospectrumasia.com/content/010806JPN1251.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct